Lianyungang, China

Ce Gao


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ce Gao in Cholic Acid Compound Development

Introduction

Ce Gao is a notable inventor based in Lianyungang, China, renowned for his contributions in the field of pharmaceutical chemistry. With a focus on developing methods for synthesizing complex compounds, Gao has successfully secured a patent that showcases his innovative approach to preparing cholic acid compounds.

Latest Patents

Gao's singular patent, titled "Method for preparing cholic acid compound," presents a novel technique involving several systematic steps. The method includes an oxidization reaction to convert a specific precursor compound, followed by the attachment of a trimethylsilyl group. Subsequent reactions include the interaction with acetaldehyde and catalytic hydrogenation, finally leading to the conversion of a cyano group to a carboxyl group, effectively producing the desired cholic acid compound as defined in his patent.

Career Highlights

Ce Gao is currently affiliated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he actively contributes to the research and development of pharmaceutical compounds. His work is instrumental in advancing therapeutic options, particularly in the synthesis of cholic acid derivatives that can benefit various medical applications.

Collaborations

Throughout his career, Gao has collaborated with esteemed colleagues such as Xiquan Zhang and Xingdong Cheng. These partnerships foster a collaborative environment that enhances the creativity and effectiveness of their research initiatives, leading to breakthroughs in drug development and compound synthesis.

Conclusion

In conclusion, Ce Gao represents the spirit of innovation in the pharmaceutical industry with his work on cholic acid compounds. His patent exemplifies a sophisticated understanding of chemical processes that pave the way for new therapeutic advancements. As he continues his journey with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Gao remains a valuable asset to the field of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…